about
The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands.Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.Death in CHARGE syndrome after the neonatal period.Gastroschisis in Europe - A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk Factors.Increased risk of septal heart defects in newborns as a result of sertraline and citalopram intake during pregnancy.Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study.Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research.First-trimester use of paroxetine and congenital heart defects: a population-based case-control study.Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.Survival and health in liveborn infants with transposition of great arteries--a population-based study.Beta-Blocker Use in Pregnancy and Risk of Specific Congenital Anomalies: A European Case-Malformed Control Study.Prenatal diagnosis of urinary tract anomalies, a cohort study in the Northern Netherlands.International trends of Down syndrome 1993-2004: Births in relation to maternal age and terminations of pregnanciesHow valid are the rates of Down syndrome internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and ResearchDrug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the NetherlandsFamily letters are an effective way to inform relatives about inherited cardiac diseaseAnalysis of Mortality among Neonates and Children with Spina Bifida: An International Registry-Based Study, 2001-2012Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study
P50
Q36240936-AFD8D320-C97A-406C-B327-8AFA5CC3736EQ36536492-711F8ADA-9902-4FE0-8924-3046DBDC7AD5Q37743670-19F8F345-A780-420C-94C5-6B9E5549BD74Q38608049-BBF09FDC-CE19-4DF1-A109-3CE7543A4C2FQ42727446-435A3433-CDD9-4970-88AC-134BDB686A06Q43008123-86881342-BD63-41AA-9F5B-E9E464B2A8BDQ43116464-1E87B5EB-75A7-4E87-BC48-6FD3C17591D8Q43235940-935E98E4-FB08-4C1D-A29E-40BB8FDA9995Q43798631-3C3E0047-145F-4160-AA6F-4E14D871110DQ45857354-809D7CD9-BCF6-4B72-B3B1-ACC625C856D4Q47325847-5BF16AFE-C723-44E5-87C8-21AA3ED2DBF9Q48118412-2C63EAFE-E8D7-48FC-99E6-D6BC93ED1106Q56988450-B3030F87-59CE-4A75-BB45-2CB60EA89ABBQ62122118-4DDF2B2F-2755-4DB0-B0B6-B7070A447AE3Q83200560-E4D0457A-BD3B-4B27-8366-2895B34ADF8DQ83336312-DACDD842-4EDC-43A5-909F-0A018A056B8BQ90866366-144C0CD1-7DBA-4E17-A773-6C0C4E146511Q91591913-C20AA5D7-8B85-488C-B788-F76710471BD3
P50
description
researcher ORCID ID = 0000-0001-5098-6400
@en
wetenschapper
@nl
name
Marian Bakker
@ast
Marian Bakker
@en
Marian Bakker
@es
Marian Bakker
@nl
type
label
Marian Bakker
@ast
Marian Bakker
@en
Marian Bakker
@es
Marian Bakker
@nl
prefLabel
Marian Bakker
@ast
Marian Bakker
@en
Marian Bakker
@es
Marian Bakker
@nl
P1153
16024192900
P21
P31
P496
0000-0001-5098-6400